MedPath

长春白求恩制药有限公司

Ownership
-
Established
1985-12-06
Employees
-
Market Cap
-
Website
http://www.bqnyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

123

NMPA:123

Drug Approvals

Levofloxacin Hydrochloride Injection

Product Name
盐酸左氧氟沙星注射液
Approval Number
国药准字H20173055
Approval Date
Jan 26, 2022
NMPA

Levofloxacin Hydrochloride Injection

Product Name
盐酸左氧氟沙星注射液
Approval Number
国药准字H20173053
Approval Date
Jan 26, 2022
NMPA

Levofloxacin Hydrochloride Injection

Product Name
盐酸左氧氟沙星注射液
Approval Number
国药准字H20173054
Approval Date
Jan 26, 2022
NMPA

复方鹿茸健骨胶囊

Approval Number
国药准字Z20060239
Approval Date
Dec 22, 2020
NMPA

Heparolysate Injection

Product Name
肝水解肽注射液
Approval Number
国药准字H20045916
Approval Date
Dec 10, 2020
NMPA

Heparolysate Injection

Product Name
肝水解肽注射液
Approval Number
国药准字H20045915
Approval Date
Dec 10, 2020
NMPA

Pefloxacin Mesylate Injectiom

Product Name
甲磺酸培氟沙星注射液
Approval Number
国药准字H10950251
Approval Date
Dec 10, 2020
NMPA

Thymopolypeptides Injection

Product Name
胸腺肽注射液
Approval Number
国药准字H20044066
Approval Date
Dec 10, 2020
NMPA

Muscular Amino Acids and Peptides and Nucleosides Injection

Product Name
肌氨肽苷注射液
Approval Number
国药准字H20046261
Approval Date
Dec 10, 2020
NMPA

Muscular Amino Acids and Peptides and Nucleosides Injection

Product Name
肌氨肽苷注射液
Approval Number
国药准字H20065548
Approval Date
Dec 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.